PKM and breast cancer: A novel glycopeptide-based PKM2 nano-activator has been developed to selectively accumulate in tumor-enriched regions, suppressing aerobic glycolysis in BC cells by sequestering PKM2 tetramers and preventing dimeric nuclear translocation.